✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Supernus Pharmaceuticals, Inc.

Common Name
Supernus Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
778
Ticker
SUPN
Exchange
Nasdaq
Description
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for central nervous system diseases. Supernus Pharmaceuticals, Inc. markets therapies f...

Supernus Pharmaceuticals's Revenues Data

Explore Supernus Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
718,952,000a
661,817,000a
607,521,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Supernus Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Supernus Pharmaceuticals's 10-K 2025